https://www.avient.com/sites/default/files/2025-01/Stethoscope Dispersions Case Study Snapshot.pdf
MEDICAL DEVICE MANUFACTURER S T E T H O S C O P E S • Provide a silicone paste colorant dispersion for liquid silicone rubber (LSR) to use in stethoscope ear tips • Create a custom-colored vinyl plastisol formulation for stethoscope tubing • Harmonize color across materials to meet specific process and performance requirements • Deliver effective communication and cross-functional collaboration • Offered dependable silicone paste colorants that allowed for comfort and easy sterilization • Provided a colored vinyl plastisol to reduce tackiness and support product longevity • Collaborated internally to align all materials and provide color consistency across components • Supported fast color changes and met quality specifications through constant communication and technical expertise Silcopas Silicone Paste Colorants and CORE Vinyl Plastisols for Healthcare KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-08/20210802-business-profile.pdf
: 14/12/1990 Company Type : PRIVATE COMPANY LIMITED BY SHARES Status : Live Company Status Date : 14/12/1990 Principal Activities Activities (I) WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT (46900) : IMPORT/EXPORT AND SALES OF POLYMERS Description : Activities (II) : Description Capital CurrencyIssued Share Capital Share TypeNumber of Shares * (AMOUNT) 694600 SINGAPORE, DOLLARS ORDINARY694600 7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY7200000 * Number of Shares includes number of Treasury Shares CurrencyPaid-Up Capital Share TypeNumber of Shares (AMOUNT) 694600 SINGAPORE, DOLLARS ORDINARY 7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY Page 1 of 4 Number Of Shares Currency COMPANY HAS THE FOLLOWING ORDINARY SHARES HELD AS TREASURY SHARES Registered Office Address 3 INTERNATIONAL BUSINESS PARK #04-14/15 NORDIC EUROPEAN CENTRE SINGAPORE (609927) Date of Address 16/08/2020: Date of Last AGM : 29/08/2020 Date of Last AR : 26/10/2020 FYE As At Date of Last AR : 31/12/2019 Audit Firms NAME ERNST & YOUNG LLP Amount Secured Chargee(s) Charges CurrencyCharge No. Date Registered ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Date of Appointment XU TAO EB6238077 CHINESE 30/06/2021ACRA DirectorROOM 102, BUILDING 20, SUB LANE 7, LANE 888, LUOJIN ROAD SHANGHAI, 201104, CHINA CHAN BAI RONG S8534833G SINGAPORE CITIZEN 30/06/2021ACRA Director10A BENDEMEER ROAD #26-103 BENDEMEER LIGHT SINGAPORE (331010) LEE SAY ENG A52290094 MALAYSIAN 30/06/2021ACRA Page 2 of 4 ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Date of Appointment Director168 JINAN ROAD, BUILDING 10, ROOM 802, SHANGHAI CHINA 200021 CHAN LAI YIN S7480587F MALAYSIAN 28/06/2010ACRA Secretary26 SIMEI STREET 1 #11-08 MELVILLE PARK SINGAPORE (529947) LEE WEI HSIUNG S7927166G SINGAPORE CITIZEN 01/12/2009ACRA Secretary633 JURONG WEST STREET 65 #10-310 SINGAPORE (640633) Shareholder(s) Name ID Nationality/Citizenship Place of incorporation/ Origin/Registration Address Changed AVIENT CORPORATION T05UF0103G UNITED STATES OF AMERICA ACRA1 33587 WALKER ROAD, AVON LAKE, OHIO 44012, UNITED STATES OF AMERICA Ordinary(Number) Currency 694600 SINGAPORE, DOLLARS Ordinary(Number) Currency 7200000 UNITED STATES OF AMERICA, DOLLARS Page 3 of 4 Abbreviation UL - Local Entity not registered with ACRA UF - Foreign Entity not registered with ACRA AR - Annual Return AGM - Annual General Meeting FS - Financial Statements OSCARS - One Stop Change of Address Reporting Service by Immigration & Checkpoint Authority.
https://www.avient.com/sites/default/files/2020-08/tpes-for-automotive-industry-bulletin.pdf
INDUSTRY BULLETIN STANDARD UNITS ONFLEX LO 7120-45N Volatile Organic Compounds VDA 278 ug/g(ppm) 41 Fogging VDA 278 ug/g(ppm) 521 Odor • Control • Dry conditions • Wet conditions SAE J1351 (15) 1-10 Scale 1 2 1 Compression Set (23°C) • 22 hours • 70 hours ASTM D395 % 14.4 14.6 Capillary Viscosity • 1341/s • 11170/s ASTM D3835 Pa*s 35 7 HVAC SYSTEMS OnFlex™ LO • Features: low VOC/FOG, low odor, good compression set, easy processing, overmolds to polypropylene • Example applications: seals and flaps in heating, ventilation and air conditioning systems CHARACTERISTICS ONFLEX™ LO ONFLEX™ AF TPE GENERAL PURPOSE TPV TPO Volatile Organic Compounds (VDA 278) Very Low Moderate Moderate Moderate Very Low Fogging (VDA 278 & DIN 75201) Very Low Moderate Moderate High Very Low Odor (VDA 270 Requirement ≤3.0) ≤3.0 ≤3.0 >3 >3 ≤3.0 Gloss Level Low Low Low Very Low High Tactile Feel Grippy Grippy Grippy Grippy Waxy Pre-Drying Required No No No Yes No Raw Material Costs $$ $$ $$ $$$ $ Compression Set @ RT Good Good Good Excellent N/A Compression Set @ ≥70°C Moderate Moderate Moderate Good N/A UV Resistance Good Excellent Good Good Good Weatherability Good Excellent Good Good Good Hardness Range Low to High Low to High Low to High Low to High High Density (g/ml) 1.15 0.99 0.90–1.20 0.95–0.98 0.90–1.20 GENERAL CHARACTERISTICS COMPARING TPE, TPV, TPO Grades shown on both pages are representative of solutions manufactured in North America, more grades available globally. INTERIORS/EXTERIORS TEMP STANDARD UNITS ONFLEX AF 7210-40B ONFLEX AF 7210-50B ONFLEX AF 7210-60B ONFLEX AF 7210-70B ONFLEX AF 7210-80B QUV Exposure • 1000 Hrs(0.68 W/m2 @ 340nm) • 2000 Hrs(0.68 W/m2 @ 340nm) 45°C ΔE 0.49 0.38 0.42 0.48 0.21 0.85 0.22 0.14 0.32 0.24 Xenon-Arc Exposure • 1000 Hrs(0.35 W/m2 @ 340nm) 63°C ΔE 0.63 0.84 0.34 — 0.58 Capillary Viscosity • 1341/s • 11170/s ASTM D3835 Pa*s 60 11.4 79 15 65 13 48 13.7 73 16 Ozone Resistance ASTM D1149(16) B Visual No cracks No cracks No cracks No cracks No cracks Low Temperature Brittleness ISO 812 B °C -63 -62 -62 -62 -62 OnFlex™ AF • Features: long-term sealing performance, reduced noise and vibration, grippy feel, low gloss, low odor, excellent UV resistance and weatherability, easy processability, overmolds to polypropylene • Example applications: trays, door pockets, fasteners, clips, roof rack pads, roof and door trim, and window encapsulations The need to innovate is virtually endless.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
• A reconciliation of each non‐GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is co pa ab e G a c a easu e s attac ed to t s p ese tat o c s posted on our website at www.polyone.com. Page 3 Strategy and Execution Drive Results 90% $22 $24 PolyOne Stock Price 50% $18 $20 $22 S&P 500 (relative performance) 30% $12 $14 $16 S&P 500 (relative performance) ‐10% 10% $6 $8 $10 50% ‐30% $0 $2 $4 $ | ‐50%$0 2006 2007 2008 2009 2010 2011 2012 2013 Page 4 Four Pillar Strategy The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized Polymer Materials, Services & Solutions Page 5 Spartech – Compelling Strategic Rationale • Spartech expands PolyOne’s specialty portfolio with adjacent technologies in attractive end markets Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only 6% of Spartech’s revenues are outside of North America • PolyOne has a proven management team with a track record of transformational success • Preliminary synergy estimated at $65 million run rate by end of 3year 3 Significant opportunity to expand profitability by leveraging PolyOne’s four pillar strategy • Substantial potential share price appreciation for all shareholders f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once synergies realized Page 6 Mix Shift Highlights Specialty Transformation Old PolyOne Transformation 100% 2015 Target 80% In co m e* 65 – 75%40% 60% f O pe ra tin g 34% 43% 45% 65 75% 20% o f 2%0% 2005 2008 2010 2012 2015 Specialty OI $5M $46M $87M $114M Target *Operating Income excludes corporate charges and special items JV's PP&S Distribution Specialty Page 7 Proof of Performance 2007 2012 2015 “Where we were” “Where we are” “Where we Where we were Where we are expect to be" 1) Operating Income % Specialty 3.2% 9.1% 12 – 16% PP&S 6.1% 9.0% 9 – 12% Distribution 3.0% 6.4% 6 – 7.5% 2) Specialty Platform sss% of Operating Income 20% 45% 65 – 75% 3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15% 4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period **4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS Page 8 Proof of Performance Spartech Opportunity Intermediate PolyOne Spartech Opportunity 2006 2012 Today Goal “Where we were” “Where we are” “Where Spartech is”* “Where we can go”were are Spartech is can go Specialty Operating Margin 1.5% 9.1% 2.2% 8.0% – 10.0% Margin Page 9 *Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012 PolyOne 14% Latin America 3% Distribution 2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion* United States 14% 5% PP&S 20%Specialty 57% Building & HealthCare 1.02 1.20 $1.20 $1.40 ha re End Markets* EPS Growth Construction 14% 17% Industrial 9% 0.27 0 21 0.79 $0.40 $0.60 $0.80 $1.00 Ad ju st ed E ar ni ng s P er S Electrical & 0.12 0.21 0.13 $0.00 $0.20 2006 2007 2008 2009 2010 2011 2012 Page 10 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms Specialty U it d 2012 Revenues: $2.4 Billion* Solutions United States 59% 9% Latin America Building & C t ti HealthCare o f S al es 12-16% End Markets* Expanding Profits Construction Electrical & Industrial 15% 1.5% 3.2% 4.3% 5.3% 8.4% 9.1% O pe ra tin g In co m e Page 11 2006 2007 2008 2009 2010 2011 2012 2015 O Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms Designed Structures and Solutions United States 2012 Revenues: $0.85 Billion* Solutions 84% Latin America 4% Building & Construction Sign & Advertising 3% Recreation & Leisure Pool & Spa 1% Distribution & Thermoform 2% Operating Income % of Sales 2012 Revenue by Industry Segment* Expanding Profits** Electrical & Electronics 23%Industrial 3% 2.2% 8 ‐ 10% 1% HealthCare 2012 2015 Target Page 12 *Pro Forma includes FY2012 results for Spartech (11/03/12 YE) **Pro Forma results include Spartech corporate allocations for FY12 Positioned for Earnings Growth 2015 Target Rev: $5B Adj. EPS: $2.50 Assumptions • High single digit organic revenue CAGR • Operating margins in mid range of 2015 targets • No global recession• No global recession • No investment in incremental PP&S capacity • Completion of 2‐3 midsize accretive acquisitions • No divestitures • Housing starts at 85% of 50 year norm by 2015 R i f t bl b l 3X N t 2012 $ • Remain comfortably below 3X Net Debt / EBITDA Page 13 Rev: $3.0B Adj.
https://www.avient.com/sites/default/files/2022-03/Edgetek-Positioning system-Application snapshot_0330.pdf
DUAL-BAND ANTENNA MANUFACTURER P O S I T I O N I N G S Y S T E M • Ceramic replacement • Miniaturization • Moldable • Formulated materials for specific Dk/Df values • Delivered lower signal loss versus ceramic • Enhanced mechanical properties and eliminated secondary processing • Provided stable dielectric performance during injection molding process Edgetek™ Dielectric Constant (Dk) Formulations KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/versaflex-hc-syringe-plunger-english.pdf
Versaflex HC - Syringe Plunger - English SYRINGE MANUFACTURER D I S P O S A B L E S Y R I N G E P L U N G E R • USP VI and ISO 10993-4,5 compliant • Sterilize by gamma & EtO • Long-term sealing performance • Low coefficient of friction (COF) • Consistent performance across barrel sizes • Provided a formulated solution that met rigorous medical application requirements • Improved global supply continuity • Increased process efficiency by replacing previous thermoset material with TPE Versaflex™ HC 2110-57B KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-08/trilliant-surgical-stapler-housing-case-study-one-pager.pdf
HEALTHCARE DEVICE OEM S U R G I C A L S T A P L E R H O U S I N G • Easy-to-mold, durable, and good aesthetics • Excellent disinfection performance and good chemical resistance • Compatible with high- and low-temperature sterilization • Delivered durable and aesthetically pleasing specialty polymer with the added benefit of processing flexibility without retooling • Passed physical, chemical and disinfection tests in different testing conditions which proved good tensile strength and chemical resistance • Achieved consistent molding shape and properties Trilliant™ HC Thermoplastics KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-01/complet-lft-aerospace-interiors.pdf
AEROSPACE INTERIORS OEM S E A T S P A C E R & A R M R E S T • Weight reduction to increase airliner fuel economy • Meet FAA safety requirements for FST compliance and 16G kinetic survivability • Agility to delivery solution within 8-month compressed product development timeline • Achieved 40% weight reduction generating $16,000 per year reduction in fuel costs • Optimized component designs for long fiber material and conducted FEA validation • Performed prototype molding and testing for load and impact specifications to expedite development Complēt™ Long Carbon Fiber PES Composite KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-nymax-pir-marine-accessories.pdf
OUTDOOR HIGH PERFORMANCE MANUFACTURER M A R I N E A C C E S S O R I E S • High strength • High UV resistance • Structural stiffness • Provided multiple nylon grades for several marine accessories • Complemented customer expertise with application development insight and technical support in material selection • Eliminated supply concerns by serving as a single, stable source for numerous materials Nymax™ PIR Post-Industrial Recycled Nylon Formulations KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2022-01/Dynaflex-Disposable syringe tip cap-Application snapshot.pdf
SYRINGE MANUFACTURING D I S P O S A B L E S Y R I N G E T I P C A P • Excellent sealing and resealing performance • No DEHP or natural rubber latex added during processing • Can be sterilized by EtO • Compliance with ISO 10993-4&5, USP Class VI Dynaflex™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?